255 related articles for article (PubMed ID: 24103556)
1. Canonical transforming growth factor-β signaling regulates disintegrin metalloprotease expression in experimental renal fibrosis via miR-29.
Ramdas V; McBride M; Denby L; Baker AH
Am J Pathol; 2013 Dec; 183(6):1885-1896. PubMed ID: 24103556
[TBL] [Abstract][Full Text] [Related]
2. The microRNA miR-433 promotes renal fibrosis by amplifying the TGF-β/Smad3-Azin1 pathway.
Li R; Chung AC; Dong Y; Yang W; Zhong X; Lan HY
Kidney Int; 2013 Dec; 84(6):1129-44. PubMed ID: 23868013
[TBL] [Abstract][Full Text] [Related]
3. Smad3-mediated upregulation of miR-21 promotes renal fibrosis.
Zhong X; Chung AC; Chen HY; Meng XM; Lan HY
J Am Soc Nephrol; 2011 Sep; 22(9):1668-81. PubMed ID: 21852586
[TBL] [Abstract][Full Text] [Related]
4. Diminution of microRNA-98 alleviates renal fibrosis in diabetic nephropathy by elevating Nedd4L and inactivating TGF-β/Smad2/3 pathway.
Zeng Y; Feng Z; Liao Y; Yang M; Bai Y; He Z
Cell Cycle; 2020 Dec; 19(24):3406-3418. PubMed ID: 33315506
[TBL] [Abstract][Full Text] [Related]
5. Expression of miR-207 in renal tissue of renal fibrosis rats and its correlation analysis with protein expression of TGF-β1 and Smad3.
Tian F; Zhang ZY; Sun J; Han YC
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):787-794. PubMed ID: 33577033
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-214 antagonism protects against renal fibrosis.
Denby L; Ramdas V; Lu R; Conway BR; Grant JS; Dickinson B; Aurora AB; McClure JD; Kipgen D; Delles C; van Rooij E; Baker AH
J Am Soc Nephrol; 2014 Jan; 25(1):65-80. PubMed ID: 24158985
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-302b mitigates renal fibrosis via inhibiting TGF-β/Smad pathway activation.
Sun M; Zhou W; Yao F; Song J; Xu Y; Deng Z; Diao H; Li S
Braz J Med Biol Res; 2021; 54(3):e9206. PubMed ID: 33503202
[TBL] [Abstract][Full Text] [Related]
8. TGF-β/Smad3 signaling promotes renal fibrosis by inhibiting miR-29.
Qin W; Chung AC; Huang XR; Meng XM; Hui DS; Yu CM; Sung JJ; Lan HY
J Am Soc Nephrol; 2011 Aug; 22(8):1462-74. PubMed ID: 21784902
[TBL] [Abstract][Full Text] [Related]
9. Introduction of miR-3613-3p as a regulator of transforming growth factor-β (TGF-β) signaling pathway in colorectal cancer.
Jafarian M; Hasannia T; Badameh P; Behmanesh M; Soltani BM
Mol Biol Rep; 2024 Jun; 51(1):728. PubMed ID: 38861185
[TBL] [Abstract][Full Text] [Related]
10. miR-29b as a therapeutic agent for angiotensin II-induced cardiac fibrosis by targeting TGF-β/Smad3 signaling.
Zhang Y; Huang XR; Wei LH; Chung AC; Yu CM; Lan HY
Mol Ther; 2014 May; 22(5):974-85. PubMed ID: 24569834
[TBL] [Abstract][Full Text] [Related]
11. The Notch γ-secretase inhibitor ameliorates kidney fibrosis via inhibition of TGF-β/Smad2/3 signaling pathway activation.
Xiao Z; Zhang J; Peng X; Dong Y; Jia L; Li H; Du J
Int J Biochem Cell Biol; 2014 Oct; 55():65-71. PubMed ID: 25150830
[TBL] [Abstract][Full Text] [Related]
12. Promoting roles of KLF5 in myocardial infarction in mice involving microRNA-27a suppression and the following GFPT2/TGF-β/Smad2/3 axis activation.
Tian Z; Zhang Y; Lyu X
Cell Cycle; 2021 May; 20(9):874-893. PubMed ID: 33910455
[TBL] [Abstract][Full Text] [Related]
13. Effects of proteasome inhibitors on rat renal fibrosis in vitro and in vivo.
Sakairi T; Hiromura K; Takahashi S; Hamatani H; Takeuchi S; Tomioka M; Maeshima A; Kuroiwa T; Nojima Y
Nephrology (Carlton); 2011 Jan; 16(1):76-86. PubMed ID: 21175982
[TBL] [Abstract][Full Text] [Related]
14. p-SMAD2/3 and DICER promote pre-miR-21 processing during pressure overload-associated myocardial remodeling.
García R; Nistal JF; Merino D; Price NL; Fernández-Hernando C; Beaumont J; González A; Hurlé MA; Villar AV
Biochim Biophys Acta; 2015 Jul; 1852(7):1520-30. PubMed ID: 25887159
[TBL] [Abstract][Full Text] [Related]
15. TGF-β induces miR-30d down-regulation and podocyte injury through Smad2/3 and HDAC3-associated transcriptional repression.
Liu L; Lin W; Zhang Q; Cao W; Liu Z
J Mol Med (Berl); 2016 Mar; 94(3):291-300. PubMed ID: 26432290
[TBL] [Abstract][Full Text] [Related]
16. [Transfected miR-1908 inhibits renal fibrosis via targeting transforming growth factor beta 1].
Xie F; Li X; Wei C; Gou L; Dang Y; Shan Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Dec; 31(12):1682-5, 1689. PubMed ID: 26648305
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II induces connective tissue growth factor and collagen I expression via transforming growth factor-beta-dependent and -independent Smad pathways: the role of Smad3.
Yang F; Chung AC; Huang XR; Lan HY
Hypertension; 2009 Oct; 54(4):877-84. PubMed ID: 19667256
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-155 targets SMAD2 and modulates the response of macrophages to transforming growth factor-{beta}.
Louafi F; Martinez-Nunez RT; Sanchez-Elsner T
J Biol Chem; 2010 Dec; 285(53):41328-36. PubMed ID: 21036908
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast-specific TGF-β-Smad2/3 signaling underlies cardiac fibrosis.
Khalil H; Kanisicak O; Prasad V; Correll RN; Fu X; Schips T; Vagnozzi RJ; Liu R; Huynh T; Lee SJ; Karch J; Molkentin JD
J Clin Invest; 2017 Oct; 127(10):3770-3783. PubMed ID: 28891814
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-24 regulates cardiac fibrosis after myocardial infarction.
Wang J; Huang W; Xu R; Nie Y; Cao X; Meng J; Xu X; Hu S; Zheng Z
J Cell Mol Med; 2012 Sep; 16(9):2150-60. PubMed ID: 22260784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
